Cerba Healthcare
Cerba Healthcare, headquartered in France, is a leading player in the global healthcare sector, specialising in laboratory services and diagnostics. Founded in 1967, the company has expanded its operations across Europe, Africa, and the Middle East, establishing a strong presence in the medical testing industry. With a commitment to innovation, Cerba Healthcare offers a comprehensive range of services, including clinical pathology, genetic testing, and specialised diagnostics. Their unique approach combines advanced technology with a patient-centric focus, ensuring high-quality results and rapid turnaround times. Recognised for its excellence, Cerba Healthcare has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and institutions. The company’s dedication to precision and reliability has solidified its reputation as a leader in the laboratory services market.
DitchCarbon Score
How does Cerba Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cerba Healthcare's score of 24 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cerba Healthcare's reported carbon emissions
In 2023, Cerba Healthcare reported total carbon emissions of approximately 339,011,000 kg CO2e. This figure includes 12,879,000 kg CO2e from Scope 1 emissions, 6,131,000 kg CO2e from Scope 2 emissions, and 320,000,000 kg CO2e from Scope 3 emissions. Within Scope 3, significant contributors included purchased goods and services at 124,800,000 kg CO2e, upstream transportation and distribution at 137,600,000 kg CO2e, and waste generated in operations at 19,200,000 kg CO2e. In 2021, the company had a total of approximately 689,105,000 kg CO2e in emissions, indicating a substantial reduction in emissions over the two-year period. The breakdown for 2021 included 7,730,000 kg CO2e from Scope 1, 4,091,000 kg CO2e from Scope 2, and a significant 677,284,000 kg CO2e from Scope 3. Despite these figures, Cerba Healthcare has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction targets suggests that while the company is actively measuring its emissions, it may not yet have formalised commitments to reduce them in line with industry standards or frameworks such as the Science Based Targets initiative (SBTi). Overall, Cerba Healthcare's emissions data reflects a commitment to transparency in reporting, with a notable decrease in total emissions from 2021 to 2023, although further details on reduction strategies would enhance their climate commitment profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2023 | |
|---|---|---|
| Scope 1 | 7,730,000 | 00,000,000 |
| Scope 2 | 4,091,000 | 0,000,000 |
| Scope 3 | 677,284,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cerba Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
